Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1.

Gur C, Maalouf N, Shhadeh A, Berhani O, Singer BB, Bachrach G, Mandelboim O.

Oncoimmunology. 2019 Mar 27;8(6):e1581531. doi: 10.1080/2162402X.2019.1581531. eCollection 2019.

PMID:
31069151
2.

The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities.

Gur C, Maalouf N, Gerhard M, Singer BB, Emgård J, Temper V, Neuman T, Mandelboim O, Bachrach G.

Oncoimmunology. 2019 Jan 29;8(4):e1553487. doi: 10.1080/2162402X.2018.1553487. eCollection 2019.

PMID:
30906650
3.

Quantification of Bacterial Attachment to Tissue Sections.

Isaacson B, Hadad T, Bachrach G, Mandelboim O.

Bio Protoc. 2018 Mar 5;8(5). pii: e2741. doi: 10.21769/BioProtoc.2741.

4.

Tumor Targeting by Fusobacterium nucleatum: A Pilot Study and Future Perspectives.

Abed J, Maalouf N, Parhi L, Chaushu S, Mandelboim O, Bachrach G.

Front Cell Infect Microbiol. 2017 Jun 30;7:295. doi: 10.3389/fcimb.2017.00295. eCollection 2017.

5.

Stromal Cell-Derived Factor 1 Mediates Immune Cell Attraction upon Urinary Tract Infection.

Isaacson B, Hadad T, Glasner A, Gur C, Granot Z, Bachrach G, Mandelboim O.

Cell Rep. 2017 Jul 5;20(1):40-47. doi: 10.1016/j.celrep.2017.06.034.

6.

Interactions of histatin-3 and histatin-5 with actin.

Blotnick E, Sol A, Bachrach G, Muhlrad A.

BMC Biochem. 2017 Mar 6;18(1):3. doi: 10.1186/s12858-017-0078-0.

7.

Sustained Release of Antibacterial Lipopeptides from Biodegradable Polymers against Oral Pathogens.

Eckhard LH, Houri-Haddad Y, Sol A, Zeharia R, Shai Y, Beyth S, Domb AJ, Bachrach G, Beyth N.

PLoS One. 2016 Sep 8;11(9):e0162537. doi: 10.1371/journal.pone.0162537. eCollection 2016.

8.

Actin and DNA Protect Histones from Degradation by Bacterial Proteases but Inhibit Their Antimicrobial Activity.

Sol A, Skvirsky Y, Blotnick E, Bachrach G, Muhlrad A.

Front Microbiol. 2016 Aug 9;7:1248. doi: 10.3389/fmicb.2016.01248. eCollection 2016.

9.

Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.

Abed J, Emgård JE, Zamir G, Faroja M, Almogy G, Grenov A, Sol A, Naor R, Pikarsky E, Atlan KA, Mellul A, Chaushu S, Manson AL, Earl AM, Ou N, Brennan CA, Garrett WS, Bachrach G.

Cell Host Microbe. 2016 Aug 10;20(2):215-25. doi: 10.1016/j.chom.2016.07.006.

10.

Interaction of the core fragments of the LL-37 host defense peptide with actin.

Sol A, Wang G, Blotnick E, Golla R, Bachrach G, Muhlrad A.

RSC Adv. 2015;5(13):9361-9367. Epub 2014 Dec 12.

11.

Streptococcus pyogenes Sortase Mutants Are Highly Susceptible to Killing by Host Factors Due to Aberrant Envelope Physiology.

Raz A, Tanasescu AM, Zhao AM, Serrano A, Alston T, Sol A, Bachrach G, Fischetti VA.

PLoS One. 2015 Oct 20;10(10):e0140784. doi: 10.1371/journal.pone.0140784. eCollection 2015.

13.

Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack.

Gur C, Ibrahim Y, Isaacson B, Yamin R, Abed J, Gamliel M, Enk J, Bar-On Y, Stanietsky-Kaynan N, Coppenhagen-Glazer S, Shussman N, Almogy G, Cuapio A, Hofer E, Mevorach D, Tabib A, Ortenberg R, Markel G, Miklić K, Jonjic S, Brennan CA, Garrett WS, Bachrach G, Mandelboim O.

Immunity. 2015 Feb 17;42(2):344-355. doi: 10.1016/j.immuni.2015.01.010. Epub 2015 Feb 10.

14.

Fap2 of Fusobacterium nucleatum is a galactose-inhibitable adhesin involved in coaggregation, cell adhesion, and preterm birth.

Coppenhagen-Glazer S, Sol A, Abed J, Naor R, Zhang X, Han YW, Bachrach G.

Infect Immun. 2015 Mar;83(3):1104-13. doi: 10.1128/IAI.02838-14. Epub 2015 Jan 5.

15.

Identification and characterization of fusolisin, the Fusobacterium nucleatum autotransporter serine protease.

Doron L, Coppenhagen-Glazer S, Ibrahim Y, Eini A, Naor R, Rosen G, Bachrach G.

PLoS One. 2014 Oct 30;9(10):e111329. doi: 10.1371/journal.pone.0111329. eCollection 2014.

16.

Biohybrid polymer-antimicrobial peptide medium against Enterococcus faecalis.

Eckhard LH, Sol A, Abtew E, Shai Y, Domb AJ, Bachrach G, Beyth N.

PLoS One. 2014 Oct 3;9(10):e109413. doi: 10.1371/journal.pone.0109413. eCollection 2014.

17.

Actin enables the antimicrobial action of LL-37 peptide in the presence of microbial proteases.

Sol A, Skvirsky Y, Nashef R, Zelentsova K, Burstyn-Cohen T, Blotnick E, Muhlrad A, Bachrach G.

J Biol Chem. 2014 Aug 15;289(33):22926-41. doi: 10.1074/jbc.M114.579672. Epub 2014 Jun 19.

18.

Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells.

Gur C, Coppenhagen-Glazer S, Rosenberg S, Yamin R, Enk J, Glasner A, Bar-On Y, Fleissig O, Naor R, Abed J, Mevorach D, Granot Z, Bachrach G, Mandelboim O.

Cell Host Microbe. 2013 Dec 11;14(6):664-74. doi: 10.1016/j.chom.2013.11.004.

19.

LL-37 opsonizes and inhibits biofilm formation of Aggregatibacter actinomycetemcomitans at subbactericidal concentrations.

Sol A, Ginesin O, Chaushu S, Karra L, Coppenhagen-Glazer S, Ginsburg I, Bachrach G.

Infect Immun. 2013 Oct;81(10):3577-85. doi: 10.1128/IAI.01288-12. Epub 2013 Jul 8.

20.

Diminished Memory T-Cell Expansion Due to Delayed Kinetics of Antigen Expression by Lentivectors.

Furmanov K, Elnekave M, Sa'eed A, Segev H, Eli-Berchoer L, Kotton DN, Bachrach G, Hovav AH.

PLoS One. 2013 Jun 18;8(6):e66488. doi: 10.1371/journal.pone.0066488. Print 2013.

21.

Oxygen deprivation affects the antimicrobial action of LL-37 as determined by microplate real-time kinetic measurements under anaerobic conditions.

Eini A, Sol A, Coppenhagen-Glazer S, Skvirsky Y, Zini A, Bachrach G.

Anaerobe. 2013 Aug;22:20-4. doi: 10.1016/j.anaerobe.2013.04.014. Epub 2013 May 8.

PMID:
23664904
22.

LL-37 induces polymerization and bundling of actin and affects actin structure.

Sol A, Blotnick E, Bachrach G, Muhlrad A.

PLoS One. 2012;7(11):e50078. doi: 10.1371/journal.pone.0050078. Epub 2012 Nov 26.

23.

Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease.

Chaushu S, Wilensky A, Gur C, Shapira L, Elboim M, Halftek G, Polak D, Achdout H, Bachrach G, Mandelboim O.

PLoS Pathog. 2012;8(3):e1002601. doi: 10.1371/journal.ppat.1002601. Epub 2012 Mar 22.

24.
25.

Garlic allicin as a potential agent for controlling oral pathogens.

Bachrach G, Jamil A, Naor R, Tal G, Ludmer Z, Steinberg D.

J Med Food. 2011 Nov;14(11):1338-43. doi: 10.1089/jmf.2010.0165. Epub 2011 May 6.

PMID:
21548800
26.

Saliva enables the antimicrobial activity of LL-37 in the presence of proteases of Porphyromonas gingivalis.

Gutner M, Chaushu S, Balter D, Bachrach G.

Infect Immun. 2009 Dec;77(12):5558-63. doi: 10.1128/IAI.00648-09. Epub 2009 Oct 5.

27.

Cranberry constituents affect fructosyltransferase expression in Streptococcus mutans.

Feldman M, Weiss E, Shemesh M, Ofek I, Bachrach G, Rozen R, Steinberg D.

Altern Ther Health Med. 2009 Mar-Apr;15(2):32-8.

PMID:
19284180
28.

Assessing the levels of immunoglobulins in the saliva of diabetic individuals with periodontitis using checkerboard immunodetection.

Bachrach G, Muster Z, Raz I, Chaushu G, Stabholz A, Nussbaum G, Gutner M, Chaushu S.

Oral Dis. 2008 Jan;14(1):51-9. doi: 10.1111/j.1601-0825.2006.01345.x.

PMID:
18173449
29.

Resistance of Porphyromonas gingivalis ATCC 33277 to direct killing by antimicrobial peptides is protease independent.

Bachrach G, Altman H, Kolenbrander PE, Chalmers NI, Gabai-Gutner M, Mor A, Friedman M, Steinberg D.

Antimicrob Agents Chemother. 2008 Feb;52(2):638-42. Epub 2007 Dec 17.

30.

Age-dependent deficiency in saliva and salivary antibodies secretion in Down's syndrome.

Chaushu S, Chaushu G, Zigmond M, Yefenof E, Stabholz A, Shapira J, Merrick J, Bachrach G.

Arch Oral Biol. 2007 Nov;52(11):1088-96. Epub 2007 Jul 20.

PMID:
17658453
32.

Salivary LL-37 secretion in individuals with Down syndrome is normal.

Bachrach G, Chaushu G, Zigmond M, Yefenof E, Stabholz A, Shapira J, Merrick J, Chaushu S.

J Dent Res. 2006 Oct;85(10):933-6.

PMID:
16998135
33.

The outcome of a preventive dental care programme on the prevalence of localized aggressive periodontitis in Down's syndrome individuals.

Zigmond M, Stabholz A, Shapira J, Bachrach G, Chaushu G, Becker A, Yefenof E, Merrick J, Chaushu S.

J Intellect Disabil Res. 2006 Jul;50(Pt 7):492-500.

PMID:
16774634
34.

In vitro assessment of antimicrobial peptides as potential agents against several oral bacteria.

Altman H, Steinberg D, Porat Y, Mor A, Fridman D, Friedman M, Bachrach G.

J Antimicrob Chemother. 2006 Jul;58(1):198-201. Epub 2006 May 10.

PMID:
16687459
35.

Soluble sustained release gene delivery system.

Bachrach G, Friedman M, Gilinski G, Steinberg D.

J Biomed Mater Res A. 2006 Jun 15;77(4):811-4.

PMID:
16575909
36.

Fluorescence based measurements of Fusobacterium nucleatum coaggregation and of fusobacterial attachment to mammalian cells.

Bachrach G, Ianculovici C, Naor R, Weiss EI.

FEMS Microbiol Lett. 2005 Jul 15;248(2):235-40.

37.

Effect of carbohydrates on fructosyltransferase expression and distribution in Streptococcus mutans GS-5 biofilms.

Rozen R, Bachrach G, Steinberg D.

Carbohydr Res. 2004 Dec 27;339(18):2883-8.

PMID:
15582615
38.

Characterization of the novel Fusobacterium nucleatum plasmid pKH9 and evidence of an addiction system.

Bachrach G, Haake SK, Glick A, Hazan R, Naor R, Andersen RN, Kolenbrander PE.

Appl Environ Microbiol. 2004 Dec;70(12):6957-62.

39.

Identification of a Fusobacterium nucleatum 65 kDa serine protease.

Bachrach G, Rosen G, Bellalou M, Naor R, Sela MN.

Oral Microbiol Immunol. 2004 Jun;19(3):155-9.

PMID:
15107066
40.

Streptococcus mutans fructosyltransferase interactions with glucans.

Rozen R, Steinberg D, Bachrach G.

FEMS Microbiol Lett. 2004 Mar 12;232(1):39-43.

41.

Molecular epidemiology of asymptomatic bacteriuria in the elderly.

Rahav G, Pinco E, Bachrach G, Bercovier H.

Age Ageing. 2003 Nov;32(6):670-3.

PMID:
14600011
42.

Effect of chlorhexidine on molecular weight distribution of fructans produced by fructosyltransferase in solution and immobilized on surface.

Rozen R, Bachrach G, Zaks B, Bronshteyn M, Gedalia I, Steinberg D.

Carbohydr Res. 2003 Mar 14;338(6):571-5.

PMID:
12668115
43.

Effects of various antiplaque agents on fructosyltransferase activity in solution and immobilized onto hydroxyapatite.

Steinberg D, Bachrach G, Gedalia I, Abu-Ata S, Rozen R.

Eur J Oral Sci. 2002 Oct;110(5):374-9.

PMID:
12664468
44.

Bacteriophage isolation from human saliva.

Bachrach G, Leizerovici-Zigmond M, Zlotkin A, Naor R, Steinberg D.

Lett Appl Microbiol. 2003;36(1):50-3.

45.

Regulation of fructosyltransferase activity by carbohydrates, in solution and immobilized on hydroxyapatite surfaces.

Steinberg D, Rozen R, Bromshteym M, Zaks B, Gedalia I, Bachrach G.

Carbohydr Res. 2002 Apr 17;337(8):701-10.

PMID:
11950466
46.

Recovery of Streptococcus iniae from diseased fish previously vaccinated with a streptococcus vaccine.

Bachrach G, Zlotkin A, Hurvitz A, Evans DL, Eldar A.

Appl Environ Microbiol. 2001 Aug;67(8):3756-8.

47.

Growth rate and biofilm thickness of Streptococcus sobrinus and Streptococcus mutans on hydroxapatite.

Rozen R, Bachrach G, Zachs B, Steinberg D.

APMIS. 2001 Feb;109(2):155-60.

PMID:
11398997
48.

The role of fructans on dental biofilm formation by Streptococcus sobrinus, Streptococcus mutans, Streptococcus gordonii and Actinomyces viscosus.

Rozen R, Bachrach G, Bronshteyn M, Gedalia I, Steinberg D.

FEMS Microbiol Lett. 2001 Feb 20;195(2):205-10.

49.

A new single-copy mycobacterial plasmid, pMF1, from Mycobacterium fortuitum which is compatible with the pAL5000 replicon.

Bachrach G, Colston MJ, Bercovier H, Bar-Nir D, Anderson C, Papavinasasundaram KG.

Microbiology. 2000 Feb;146 ( Pt 2):297-303.

PMID:
10708368
50.

Supplemental Content

Loading ...
Support Center